Distribution of NeutriSci’s THC/CBD Products to Commence in California

VANCOUVER, BC / ACCESSWIRE / March 13, 2020 / NeutriSci International Inc. (“NeutriSci” or the “Company”) (OTCQB:NRXCF)(TSXV:NU)(FRANKFURT:1N9) is pleased to announce that Cryopharm Corp. (“Cryopharm“), its US manufacturing and distribution partner, is completing the packaging of NeutriSci and Cryopharm’s CBD/THC products in preparation for initial distribution to more than 90 dispensaries across the state of California, with the distribution network expected to grow to over 350 dispensaries in Q2/2020.

Cryopharm’s Marbl Melts™ represent an industry-first cannabis infused product; flavorful, micro dosed, rapidly dissolvable oral melts infused with THC & CBD. NeutriSci’s core ingredients form the basis of Marbl Melts™, which contain a clinically tested dosage providing on-set in as little as 12 minutes; compared to traditional cannabinoid infusion methods that often have incorrect dosages while potentially taking up to 120 minutes to become active. Marbl Melts™ are available in several unique offerings designed for specific uses such as sleep, energy, relaxation and pain relief.

NeutriSci’s Zenstix™ and Dablets™: quick melting tabs that activate faster when compared to other cannabis edibles with a powerful 10mg dose. Each stick includes 6 tablets in a child-resistant package. This calorie-free product comes in three flavors (lemon lime, iced pomegranate and raspberry lemonade) and doesn’t contain sugar or artificial flavors.

Glen Rehman, CEO of NeutriSci, stated: “California has always been our primary objective; now that California production and distribution has begun, we will shift our focus to the production and distribution of our new products into Oklahoma, Nevada and Michigan. Revenue generation for NeutriSci includes production, distribution, ingredient sales, royalty and packaging. We also continue to expand the research and development of additional new products using our IP, technologies and ingredients to bring new product lines to existing markets and to our existing partner relationships.”

About NeutriSci International Inc.

NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci’s is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries.

Neuenergy® contains a unique patented combination of blueberry extract (pterostilbene) and naturally derived caffeine, and is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. To find out more about neuenergy®, please visit www.getneuenergy.com.

For more information, please visit: www.neutrisci.com.


Glen Rehman
Tel: (403) 264-6320
Email: investors@neutrisci.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

SOURCE: NeutriSci International Inc.

View source version on accesswire.com:

error: Content is protected !!